FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• LAMISIL AT (TERBINAFINE HYDROCHLORIDE)

Snippet

SUPPL AP for LAMISIL AT (TERBINAFINE HYDROCHLORIDE)